Corporate Research

The Novartis Corporate Research institutes foster collaboration and access talent pools throughout the world. Corporate Research works to contribute drugs and vaccines for neglected diseases through drug discovery and vaccine research at NITD and NVGH; contributes to new therapeutic targets, technologies and drug discovery through GNF; and contributes to the discovery of the basic molecular mechanisms of cells and organisms in health and disease through FMI.

Corporate Research comprises four institutes:

• The Novartis Institute for Tropical Diseases (NITD) in Singapore
• The Novartis Vaccines Institute for Global Health (NVGH) in Siena, Italy
• The Genomics Institute of the Novartis Research Foundation (GNF) in La Jolla, California
• The Friedrich Miescher Institute for Biomedical Research (FMI) in Basel, Switzerland